| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP2081938A2 Substituted 8-piperidinyl-2-pyridinyl-pyrimido ý1,2-a¨pirimidin-6-one and 8-piperidinyl-2-pyrimidi nyl-pyrimidoý1,2,-a¨pyrimidin-6-one derivatives |
| 07/29/2009 | EP2081916A1 Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
| 07/29/2009 | EP2081649A2 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 07/29/2009 | EP2081600A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 07/29/2009 | EP2081587A2 Alpha-msh therapies for treatment of autoimmune disease |
| 07/29/2009 | EP2081580A1 Polyethylene glycol-g-csf conjugate |
| 07/29/2009 | EP1653955A4 Hydroxylamine substituted imidazo-containing compounds |
| 07/29/2009 | EP1435910B1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1389043B1 Foot and mouth disease virus vaccine |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1307223B1 Parenteral vaccine formulations and uses thereof |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | EP1073463B1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 07/29/2009 | EP1036327B1 HLA-E binding to CD94/NKG2+ cells |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566708 Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors |
| 07/28/2009 | US7566698 Extracted from plants such as Ningxia Lycium barbarum L. and/or Lycium chinense Mill; glucosyltransferases, cellulases; provitamin C with improved stability and bioavailability; ultraviolet damage protector; antiwrinkling; whitening |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/23/2009 | WO2009091291A1 N-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5h-pyrimidinesulfone)-isonicotinoyl hydrazide silver salt |
| 07/23/2009 | WO2009090976A1 Transmucosal therapeutic preparation for nasal obstruction |
| 07/23/2009 | WO2009090656A2 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 07/23/2009 | WO2009089858A1 COMBINATION OF AN ANTI-EDb FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART |
| 07/23/2009 | WO2009089568A1 Immunomodulating compositions and uses therefor |
| 07/23/2009 | WO2009052081A4 Antibodies that bind il-4 and/or il-13 and their uses |
| 07/23/2009 | WO2009046845A3 Use of a lactoferrin partial peptide peptide as a therapeutic agent |
| 07/23/2009 | WO2009043523A3 Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| 07/23/2009 | WO2009040084A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009040034A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009039973A3 Use of peptide arg-asn-ile-ala-glu-ile-ile-lys-asp-ile-oh or its combination with the peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/23/2009 | WO2009038759A3 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 07/23/2009 | WO2009033816A3 Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent |
| 07/23/2009 | WO2009033773A3 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 07/23/2009 | WO2009033761A3 Use of a fragment of hcv nucleo protein, alone or together with endothelin-3, as a therapeutic agent |
| 07/23/2009 | WO2008155777A3 Process for preparing efletrizine |
| 07/23/2009 | WO2008136736A8 Immunoregulatory structures from normally occurring proteins |
| 07/23/2009 | WO2008133684A8 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 07/23/2009 | WO2008125901A8 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |
| 07/23/2009 | WO2008033069A8 Selective chemokine modulation |
| 07/23/2009 | WO2007096854A8 Compositions and methods for modulating an immune response |
| 07/23/2009 | WO2007092939A8 Antigenic gm-csf peptides and antibodies to gm-csf |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186855 antagonists; oligopeptide of N-(3-indolylacetyl)-L-isoleucine and glycine; IBD, sepsis, periodontal disease, mucositis, acne, cardiovascular disease, COPD, arthritis, cystic fibrosis, infections, ischemia/reperfusion, asthma, stroke, brain injuries, enterocolitis, bed sores, leprosy, atopic dermatitis |
| 07/23/2009 | US20090186833 Method for producing pectin hydrolysis products |
| 07/23/2009 | US20090186802 Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
| 07/23/2009 | US20090186378 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration |
| 07/23/2009 | US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses |
| 07/23/2009 | US20090186040 DOSING METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-Ig FUSION PROTEIN SUCH AS ATACICEPT |
| 07/23/2009 | US20090186037 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186021 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents |
| 07/23/2009 | US20090186018 Compositions and methods for the treatment of rheumatoid arthritis |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2009 | DE4418115B4 Galenische Formulierungen Pharmaceutical formulations |
| 07/23/2009 | CA2712404A1 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 07/23/2009 | CA2711902A1 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 07/23/2009 | CA2711145A1 Immunomodulating compositions and uses therefor |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2079833A1 Compositions and methods for immunotherapy |
| 07/22/2009 | EP2079745A1 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 07/22/2009 | EP2079740A2 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 07/22/2009 | EP2079725A1 Piperidyl-propane-thiol ccr3 modulators |
| 07/22/2009 | EP2079676A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 07/22/2009 | EP2079481A1 Vaccine peptide combinations against cat allergy |
| 07/22/2009 | EP2079478A2 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/22/2009 | EP2079459A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 07/22/2009 | EP1940464B1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 07/22/2009 | EP1648452B1 2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1432791B1 Alphavirus replicon vector systems |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1255563B1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1093381B2 Antigenic peptides derived from telomerase |
| 07/22/2009 | EP0873135B1 Peanut allergens and methods |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515496C Immunity regulator and its application |